COGT News and Press, Cogent Biosciences Inc Com From 11/12/20

Cogent Biosciences to Present at Jefferies 2020 Virtual London Healthcare Conference PR Newswire CAMBRIDGE, Mass., Nov. 12, 2020 CAMBRIDGE, Mass. , Nov. 12, 2020 /PRNewswire/ -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focuse...

Cogent Biosciences (COGT): Q3 GAAP EPS of -$5.07 misses by $4.91.Revenue of $0.31M (-69.6% Y/Y)Press Release For further details see: Cogent Biosciences EPS misses by $4.91

Cogent Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate Updates Andrew Robbins appointed President, CEO and Director Final results from PLX9486 + sunitinib Phase 1/2 study in GIST patients selected for oral presentation at Connective Tissue Onc...

Cogent Biosciences to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference PR Newswire CAMBRIDGE, Mass., Nov. 5, 2020 CAMBRIDGE, Mass. , Nov. 5, 2020 /PRNewswire/ -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focu...

Gainers: DBV Technologies (DBVT) +61%, AnPac Bio-Medical Science (ANPC) +16%, Community Health Systems (CYH) +15%, ProPhase Labs (PRPH) +12%, ZIOPHARM Oncology (ZIOP) +10%.Losers: Liquidia Technologies (LQDA) -28%, Jounce Therapeutics (JNCE) -...

Cogent Biosciences Appoints Andrew Robbins as Chief Executive Officer Seasoned executive with deep experience developing precision medicines for genetically defined diseases, most recently as COO of Array Biopharma PR Newswire CAMBRIDGE, Mass., Oct. 26, 2020 CA...